Open AccessA Phase II Study of Docetaxel and Epirubicin in Advanced Adult Soft Tissue Sarcomas (STS)
Author(s) -
Haralabos P. Kalofonos,
Charalabos Kourousis,
Michalis V. Karamouzis,
Gregoris Iconomou,
Ekaterini Tsiata,
Fotis Tzorzidis,
Panagiotis Megas,
E. Lambiris,
Vasilios Georgoulias
Publication year - 2004
Publication title -
sarcoma
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.781
H-Index - 41
eISSN - 1369-1643
pISSN - 1357-714X
DOI - 10.1155/2004/573035
Subject(s) - docetaxel , epirubicin , medicine , neutropenia , chemotherapy , algorithm , cyclophosphamide , mathematics
Purpose: The aim of this study was to determine the efficacy and safety of docetaxel plus epirubicin combination as first-linechemotherapy in patients with locally advanced and/or metastatic adult STS
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom